tirzepatide diabetes type 1 Peptide of the Week: Tirzepatide, a Game Changer for 2 and Obesity Management Tirzepatide: A Promising Drug for

- **Cardiovascular Risk Reduction** Semaglutide and dulaglutide reduce major adverse cardiovascular events in T2DM with ASCVD

Petrangolini, G., Corti, F., Ronchi, M., Arnoldi, L., Allegrini, P., & Riva, A

Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD

For details on BPC-157 protocols, see our BPC-157 dosing guide

This is where a moisturiser for skin brightening comes in

Dan Bessesen, an endocrinologist and director of the CU Anschutz Health and Wellness Center at the University of Colorado